Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Apr 30, 2025Apr 30, 2025Myers Scott Dunseth
Dir
BuyZentalis Pharmaceuticals, Inc.ZNTL$1.4$29,373+6.95%
Apr 12, 2023Apr 12, 2023Myers Scott Dunseth
CEO
BuyViridian Therapeutics, Inc.deVRDN$25.37$101,479+1.52%
Mar 13, 2023Mar 13, 2023Myers Scott Dunseth
CEO
BuyViridian Therapeutics, Inc.deVRDN$29.15$160,324+2.11%
Aug 11, 2017Aug 14, 2017Myers Scott Dunseth
Pres
CEO
BuyCascadian Therapeutics, Inc.CASC$3.74$20,543+9.96%
May 12, 2017May 16, 2017Myers Scott Dunseth
Pres
CEO
BuyCascadian Therapeutics, Inc.CASC$4$11,192+5.96%
Mar 31, 2017Apr 04, 2017Myers Scott Dunseth
Pres
CEO
BuyCascadian Therapeutics, Inc.CASC$4.11$8,229+4.61%
Mar 20, 2017Mar 22, 2017Myers Scott Dunseth
Pres
CEO
BuyCascadian Therapeutics, Inc.CASC$3.93$3,927+2.47%
Jan 27, 2017Jan 31, 2017Myers Scott Dunseth
Pres
CEO
BuyCascadian Therapeutics, Inc.CASC$3.76$77,039+34.80%
Aug 17, 2016Aug 18, 2016Myers Scott Dunseth
Pres
CEO
BuyCascadian Therapeutics, Inc.CASC$1.15$51,746+29.51%
Jun 28, 2016Jun 28, 2016Myers Scott Dunseth
Pres
CEO
BuyCascadian Therapeutics, Inc.CASC$0.8$50,000+50.00%